名稱 | NCOA4-RET/BaF3 |
型號(hào) | CBP73265 |
報(bào)價(jià) | ![]() |
特點(diǎn) | NCOA4-RET/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- EGFR 20外顯子突變類型標(biāo)準(zhǔn)品
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機(jī)制
- 免疫療法對(duì)一類常見(jiàn)白血病顯療效
- JCI:中山大學(xué)科學(xué)家找到可能*治愈常見(jiàn)白血病的新靶點(diǎn)
- 你知道乳酸對(duì)腫瘤細(xì)胞有哪些作用嗎?
- 【產(chǎn)品推介】胰高血糖素受體藥物細(xì)胞篩選模型
- 剖析正常細(xì)胞是如何成長(zhǎng)為腫瘤細(xì)胞的
- PLoS ONE:科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- 【產(chǎn)品推介】MSI標(biāo)準(zhǔn)品
- 選擇進(jìn)口的細(xì)胞株這幾點(diǎn)千萬(wàn)不能忘!
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73265NCOA4-RET/BaF3

- 詳細(xì)內(nèi)容
CBP73265 | |
I. Introduction | |
Cell Line Name: | NCOA4-RET/BaF3 |
Host Cell: | BA/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
NCOA4, nuclear receptor coactivator 4, is an androgen receptor coactivator (PMID: 15166229) and autophagy receptor that degrades ferritin complexes (PMID: 31061094) and plays a role in iron homeostasis (PMID: 30930742). NCOA4 fusions are frequently observed with RET in papillary thyroid carcinoma (also referred to as RET/PTC3) (PMID: 25731779) and have been reported in salivary intraductal carcinoma (PMID: 31162284), spindle cell tumors (PMID: 30938880), breast cancer (PMID: 30446652), colorectal cancer (PMID: 30210625), and lung cancer (PMID: 30038711). | |
III. Representative Data | |
1. WB of NCOA4-RET/BaF3 | |
2. Anti-proliferation assay | |
Figure 2. CTG assay of for NCOA4-RET/BaF3 Stable Cell Line. |